The Rx Spot's semaglutide ordering model — what to understand first
The Rx Spot is built primarily as a white-label patient storefront platform. Operators configure a custom-domain site where patients browse GLP-1 products — including compounded semaglutide and tirzepatide — go through intake, and check out directly. The Rx Spot's FAQ also notes that operators can place bulk in-office orders, but the default architecture is storefront-first, with operators setting their own tiered and volume-based retail pricing rather than seeing pass-through 503A cost. Per-vial semaglutide rates for B2B operators are not published publicly and arrive after a sales conversation.
For clinics that already prescribe and want to batch today's titration refills — picking vial sizes for each patient's current step, validating before payment, and checking out the whole roster at once — that storefront architecture is a different tool. What you should evaluate is whether the platform supports the specific semaglutide ordering workflow your clinic runs: per-vial cost on each step, pre-pay validation, and batch checkout across existing patients rather than building a new patient-facing DTC brand.